id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2023-N-4917-0001,FDA,FDA-2023-N-4917,Advisory Committee; Genetic Metabolic Diseases Advisory Committee; Establishment,Notice,Advisory Committee,2023-12-13T05:00:00Z,2023,12,2023-12-13T05:00:00Z,2024-02-13T04:59:59Z,2024-02-13T02:00:24Z,2023-27304,0,0,09000064863313f1